CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

Clinical and Laboratory Standards Institute, 02/01/2008

Publisher: CLSI

File Format: PDF

$108.00$216.21

Description

Published:01/02/2008

Pages:44

Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI M42A

Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Approved Guideline , M42-A

$126.00 $252.91

CLSI C03-A4

Preparation and Testing of Reagent Water in the Clinical Laboratory; Approved Guideline - C03A4

$145.00 $290.47

CLSI VET03-A

Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Approved Guideline , VET03AE

$90.00 $180.00

CLSI MM11P

Molecular Methods for Bacterial Strain Typing; Proposed Guideline, MM11-P

$115.00 $230.43